South Korean biotechnology firm MedySapiens was recognized for its innovation in rare disease diagnostics. The company announced Monday that it received the Next Innovator award at NextRise 2025, Korea’s largest startup fair co-hosted by the Korea Development Bank and the Korea International Trade Association. MedySapiens was honored with the award, which is given to high-potential companies with breakthrough technologies and strong business scalability, due to the technical excellence of its proprietary rare disease diagnostic platform and its potential for success in global markets.

Reference: https://pulse.mk.co.kr/news/english/11356559